Prognostic factors for survival in metastatic renal cell carcinoma patients with brain metastases receiving targeted therapy.
Yildiz I, Bilici A, Karadurmuş N, Ozer L, Tural D, Kaplan MA, Akman T, Bayoglu IV, Uysal M, Yildiz Y, Tanriverdi Ö, Yazici O, Sürmeli Z, Serdar Turhal N, Bavbek S, Selçukbiricik F, Koca D, Basaran M.
Yildiz I, et al. Among authors: basaran m.
Tumori. 2018 Dec;104(6):444-450. doi: 10.5301/tj.5000635. Epub 2018 May 9.
Tumori. 2018.
PMID: 28731496